Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Colorectal Neoplasms 3 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Spinocerebellar Degenerations 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma 1 PD-L1-selected Solid Tumors 1 Melanoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Chordoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Advanced Solid Malignancies 1 Advanced Rare Malignant Solid Neoplasm 1 Advanced Liver Cancers 1

Interventions

pembrolizumab 46 Paclitaxel 42 Carboplatin 34 Bevacizumab 18 Specimen Handling 17 Letrozole 16 lenvatinib 13 Magnetic Resonance Spectroscopy 12 dostarlimab 11 Cisplatin 11 Biopsy 11 olaparib 10 Taxes 10 Fulvestrant 9 Doxorubicin 9 abemaciclib 8 Megestrol Acetate 8 Docetaxel 8 durvalumab 7 atezolizumab 7 Nivolumab 7 Gemcitabine 7 Blood Specimen Collection 7 palbociclib 6 Oxaliplatin 6 Observation 6 Fluorouracil 6 niraparib 5 Tirzepatide 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Tiragolumab × 1 year × Clear all

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡